The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Milestone Pharmaceuticals (MIST) announced that it has received Notice of Allowance from the United States Patent and Trademark Office, or ...

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.

The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...

Mr. Pyszczymuka is a proven commercial leader with extensive experience in pharmaceutical sales, market access, and revenue ...

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

The kits include two Narcan nasal spray devices with instructions for the proper administration and steps to be taken in the ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has ...

Seventy-eight-year-old Joe Walsh, of Quincy, is in a unique position. He is the first patient to have permission from the U.S. Food and Drug Administration to try a nasal spray for moderate ...

The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...

Many recalls come as a result of product mislabeling, safety issues or contamination. Here are five recalls in particular ...